Cite
Sacristán D, Marques M, Zamorano-León JJ, et al. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl. 2008;2(9):1300-12doi: 10.1002/prca.200700021.
Sacristán, D., Marques, M., Zamorano-León, J. J., Luque, M., Armengol, J., Del Castillo, J., Martín, J., Delpón, E., Ramos-Mozo, P., de Prada, T. P., Tamargo, J., Barrientos, A., Macaya, C., & López-Farré, A. (2008). Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics. Clinical applications, 2(9), 1300-12. https://doi.org/10.1002/prca.200700021
Sacristán, Daniel, et al. "Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients." Proteomics. Clinical applications vol. 2,9 (2008): 1300-12. doi: https://doi.org/10.1002/prca.200700021
Sacristán D, Marques M, Zamorano-León JJ, Luque M, Armengol J, Del Castillo J, Martín J, Delpón E, Ramos-Mozo P, de Prada TP, Tamargo J, Barrientos A, Macaya C, López-Farré A. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl. 2008 Sep;2(9):1300-12. doi: 10.1002/prca.200700021. Epub 2008 Jul 21. PMID: 21136924.
Copy
Download .nbib